IMPROVED BETA-CELL FUNCTION, WITH REDUCTION IN SECRETION OF INTACT AND 32/33 SPLIT PROINSULIN, AFTER DIETARY INTERVENTION IN SUBJECTS WITH TYPE-2 DIABETES-MELLITUS

被引:30
作者
DAVIES, MJ
METCALFE, J
DAY, JL
GRENFELL, A
HALES, CN
GRAY, IP
机构
[1] Ipswich Diabetes Centre, Ipswich Hospital, London
[2] Central Middlesex Hospital, London
[3] Department of Clinical Biochemistry, Addenbrookes Hospital, Cambridge
[4] St Mary's Hospital, London
关键词
TYPE-2; DIABETES-MELLITUS; DIET; INSULIN; 32/33 SPLIT PROINSULIN; 2-SITE IMMUNORADIOMETRIC ASSAY;
D O I
10.1111/j.1464-5491.1994.tb00233.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diet in Type 2 diabetes often reduces both hyperglycaemia and weight and both these factors may contribute to improvement in beta cell function. Sixty-nine subjects with newly diagnosed Type 2 diabetes had their glucose, insulin, intact and 32/33 split proinsulin measured at diagnosis, and after 16 (12-20) weeks of conventional diet. In the whole group following diet there was reduction in weight (p < 0.0001), Haemoglobin A1 (p < 0.0001), and fasting glucose (p < 0.0001). There was a fall in fasting intact proinsulin (p < 0.03), 32/33 split proinsulin (p < 0.0001), and the percentage of fasting proinsulin to total insulin-like molecules (p < 0.0001). Subjects were separated according to weight loss (group 1 < 0.5 kg, group 2 0.5-4 kg, group 3 > 4 kg). Only subjects in group 3 (mean weight loss 6.2 kg) had a fall in fasting insulin (p < 0.04). The fasting glucose achieved following diet was positively correlated with the initial fasting glucose (r = 0.7) and negatively correlated with the degree of insulin deficiency at diagnosis (with the initial 30 min insulin r = -0.62). The effect of diet on the final concentration of insulin, 32/33 split proinsulin and intact proinsulin was examined using multiple regression. The final insulin concentration was determined by the initial BMI and absolute weight loss, 32/33 split proinsulin concentration by the initial fasting glucose and absolute glucose fall, and intact proinsulin concentration by a combination of both weight loss and glucose reduction. We conclude that diet without weight loss increases the insulin secreted relative to the glucose concentration and reduces the concentration of proinsulin-like molecules. Weight loss reduces insulin resistance thereby lowering the insulin and intact proinsulin concentrations.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 28 条
  • [1] Temple RC, Clarke PMS, Hales CN, Measurement of insulin secretion in type 2 diabetes: problems and pitfalls, Diabetic Med, 9, pp. 503-512, (1992)
  • [2] Davies MJ, Rayman G., Day JL, Gray IP, Hales CN, Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance, Diabetic Med, 10, pp. 313-320, (1993)
  • [3] Mitrakou A., Kelley D., Mokan M., Veneman T., Pangburn T., Reilly J., Et al., Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance, N Engl J Med, 326, pp. 22-29, (1992)
  • [4] Saad MF, Kahn SE, Nelson RG, Disproportionately elevated proinsulin in Pima Indians with non‐insulin‐dependent diabetes mellitus, The Journal of Clinical Endocrinology & Metabolism, 70, pp. 1247-1253, (1990)
  • [5] Gorden P., Hendricks CM, Roth J., Circulating proinsulin‐like component in man: increased proportion in hypoinsulinaemic states, Diabetologia, 10, pp. 469-474, (1974)
  • [6] Mako ME, Starr JI, Rubenstein AH, Circulating proinsulin in patients with maturity onset diabetes, Am J Med, 63, pp. 865-869, (1977)
  • [7] Williams DRR, Byrne C., Clark PMS, Cox L., Day NE, Hales CN, Et al., Raised proinsulin as an early indicator of b̃ cell function, Br Med J, 303, pp. 95-96, (1991)
  • [8] Yoshioka N., Kuzuya T., Matsuda A., Taniguchi M., Iwamoto Y., Serum proinsulin levels at fasting and after glucose load in patients with type 2 (non‐insulin‐dependent) diabetes mellitus, Diabetologia, 31, pp. 355-360, (1988)
  • [9] Tillil H., Frank BH, Pekar AH, Broelsch C., Rubenstein AH, Polonsky KS, Hypoglycaemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites, Endocrinology, 127, pp. 2418-2422, (1990)
  • [10] Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Et al., Biosynthetic human proinsulin